RENESE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Renese, and when can generic versions of Renese launch?
Renese is a drug marketed by Pfizer and is included in two NDAs.
The generic ingredient in RENESE is polythiazide; reserpine. There is one drug master file entry for this compound. Additional details are available on the polythiazide; reserpine profile page.
Summary for RENESE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 38 |
Patent Applications: | 4,032 |
Formulation / Manufacturing: | see details |
DailyMed Link: | RENESE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for RENESE
US Patents and Regulatory Information for RENESE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pfizer | RENESE | polythiazide | TABLET;ORAL | 012845-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Pfizer | RENESE-R | polythiazide; reserpine | TABLET;ORAL | 013636-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Pfizer | RENESE | polythiazide | TABLET;ORAL | 012845-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Pfizer | RENESE | polythiazide | TABLET;ORAL | 012845-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |